Beranda › Kanker Paru Non-Sel Kecil › Missouri › Springfield
Uji klinis Kanker Paru Non-Sel Kecil di Springfield, MO
10 studi untuk Kanker Paru Non-Sel Kecil mencari peserta di lokasi sekitar Springfield (dalam radius sekitar 30 mil). Buka studi untuk melihat kriteria peserta dan cara menghubungi tim studi.
Teks studi resmi (Bahasa Inggris)
Merekrut peserta untuk studi di sini? Tampilkan di bagian atas halaman ini — $99 selama 30 hari →
A Study to Assess Disease Activity and Adverse Events of Intravenous (IV) Telisotuzumab Vedotin Compared to IV Docetaxel in Adult Participants With Previously Treated Non-Squamous Non-Small Cell Lung Cancer (NSCLC)
Menerima pesertaFase 3
- Hulston Cancer Center /ID# 232226, Springfield
A Study of Calderasib (MK-1084) Plus Pembrolizumab (MK-3475) in Participants With KRAS G12C Mutant Non-small Cell Lung Cancer (NSCLC) With Programmed Cell Death Ligand 1 (PD-L1) Tumor Proportion Score (TPS) ≥50% (MK-1084-004/KANDLELIT-004)
Menerima pesertaFase 3
- Cox Medical Center North ( Site 0133), Springfield
A Study of Amivantamab in Combination With Lazertinib, or Amivantamab in Combination With Platinum-Based Chemotherapy, for Common Epidermal Growth Factor Receptor (EGFR)-Mutated Locally Advanced or Metastatic Non-Small Cell Lung Cancer (NSCLC)
Menerima pesertaFase 2
- Oncology Hematology Associates, Springfield
Testing Osimertinib as a Treatment for Lung Cancers With an EGFR Exon 20 Change
Menerima pesertaFase 2
- Mercy Hospital Springfield, Springfield
- CoxHealth South Hospital, Springfield
Pan-tumor MRD Study
Menerima pesertaStudi observasional
- Cox Health, Springfield
A Study of First-Line Olomorasib (LY3537982) and Pembrolizumab With or Without Chemotherapy in Patients With Advanced KRAS G12C-Mutant Non-small Cell Lung Cancer
Menerima pesertaFase 3
- Oncology Hematology Associates, Springfield
Testing Proton Craniospinal Radiation Therapy Versus the Usual Radiation Therapy for Leptomeningeal Metastasis, RADIATE-LM Trial
Menerima pesertaFase 3
- Mercy Hospital Springfield, Springfield
Predicting Response to Immunotherapy From Analysis of Live Tumor Biopsies (ELEPHAS-05)
Menerima pesertaStudi observasional
- Mercy Hospital - SPG, Springfield
Assessing Benefits and Harms of Cannabis/Cannabinoid Use Among Cancer Patients Treated in Community Oncology Clinics
Menerima pesertaStudi observasional
- Mercy Hospital Springfield, Springfield
- Cox Health South Hospital, Springfield
GEMINI-NSCLC: NSCLC Biomarker Study
Menerima pesertaStudi observasional
- Mercy Clinic Cancer and Hematology - Chub O'Reilly Cancer Center, Springfield
- Oncology Hematology Associates, Springfield
Uji klinis Kanker Paru Non-Sel Kecil di kota lain
- Houston, TX145 studi
- New York City, NY121 studi
- Arlington, VA104 studi
- Nashville, TN97 studi
- Boston, MA90 studi
- Los Angeles, CA87 studi
- St. Louis, MO73 studi
- Chicago, IL61 studi
- Baltimore, MD60 studi
- San Antonio, TX59 studi
- Columbus, OH57 studi
- Washington, DC55 studi
Studi lain di Springfield
- Kanker Kolorektal11 studi
- Kanker (semua jenis)10 studi
- Kanker Payudara10 studi
- Obesitas7 studi
- Kelebihan Berat Badan7 studi
- Melanoma6 studi
- Kanker Paru6 studi
- Kanker Metastatik6 studi
- Kanker Ovarium5 studi
- Kanker Kolon5 studi
- Kanker Kandung Kemih4 studi
- Kanker Prostat4 studi
Dari ClinicalTrials.gov, data diambil 6 Okt 2026. Setiap studi menetapkan kriteria kelayakannya sendiri; tim studi yang menentukan siapa yang bisa bergabung.